Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 3.47%.

  • MDxHealth's EBITDA Margin rose 200600.0% to 3.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39%, marking a year-over-year increase of 204700.0%. This contributed to the annual value of 16.29% for FY2024, which is 113200.0% up from last year.
  • According to the latest figures from Q3 2025, MDxHealth's EBITDA Margin is 3.47%, which was up 200600.0% from 5.11% recorded in Q2 2025.
  • MDxHealth's 5-year EBITDA Margin high stood at 239421.35% for Q3 2021, and its period low was 287608.16% during Q2 2022.
  • Its 5-year average for EBITDA Margin is 12082.61%, with a median of 16.59% in 2024.
  • Its EBITDA Margin has fluctuated over the past 5 years, first crashed by 2000000000bps in 2022, then surged by 2000000000bps in 2023.
  • Quarter analysis of 5 years shows MDxHealth's EBITDA Margin stood at 123.27% in 2021, then soared by 47bps to 181.48% in 2022, then tumbled by -112bps to 22.53% in 2023, then soared by 75bps to 5.57% in 2024, then surged by 162bps to 3.47% in 2025.
  • Its EBITDA Margin stands at 3.47% for Q3 2025, versus 5.11% for Q2 2025 and 5.48% for Q1 2025.